行为障碍治疗市场－全球产业规模、份额、趋势、机会及预测（按类型、疗法、地区和竞争格局划分，2021-2031年）

全球破坏性行为障碍治疗市场预计将从 2025 年的 186 万美元成长到 2031 年的 257 万美元，复合年增长率为 5.54%。

该市场涵盖多种药物和心理治疗干预措施，旨在管理行为问题，例如对立性反抗症和品行障碍。这一增长趋势主要得益于临床上对儿童精神疾病的认识不断提高，以及健全的诊断框架的引入，从而实现早期疗育。政府加大投入，致力于将精神健康服务与基层医疗系统整合，进一步强化了这些潜在驱动因素。世界卫生组织（世卫组织）强调了治疗管理的迫切需求，并估计到2025年，全球约有3.3%的10至14岁青少年患有品行障碍。

儘管成长指标积极，但市场仍面临一个重大障碍：全球儿童精神科医生和心理健康专业人员严重短缺。人力不足导致患者诊断和治疗服务严重受阻，这问题在发展中地区尤为突出。因此，训练有素的医疗保健人员短缺限制了治疗方案的广泛实施，儘管临床需求旺盛，但市场潜在规模却受到抑制。

市场驱动因素

对立性反抗症 (ODD) 和品行障碍 (CD) 盛行率的上升是市场扩张的主要驱动因素，也因此迫切需要更多治疗选择。行为障碍诊断数量的增加反映了青少年整体心理健康状况的下降，从而推动了对药物治疗和心理社会干预的需求。根据美国疾病管制与预防中心 (CDC) 于 2024 年 8 月发布的《2013-2023 年青少年风险行为调查资料摘要和趋势报告》，到 2023 年，约 40% 的高中生将经历持续的悲伤或绝望感，这凸显了加强对行为健康服务的迫切需求。为了服务不断增长的患者群体，医疗保健提供者正面临压力，需要实施更积极的诊断和治疗通讯协定，以应对日益增加的行为障碍症状。

与临床需求同步成长的还有政府对儿童心理健康领域的投入，这些投入显着增加，旨在减少就医障碍并补贴治疗费用。联邦和州政府机构正在增加津贴，将行为健康服务融入学校和社区中心，从而扩大直接服务对象。例如，美国药物滥用和精神健康服务管理局 (SAMHSA) 在 2024 年 7 月的新闻稿中宣布了一项 1530 万美元的专项拨款，用于透过校内心理健康服务支持儿童，并为患有严重情绪障碍的儿童提供支持。公共投资的激增也带动了私部门的乐观情绪。根据 MedCity News 2024 年 10 月的一篇文章报道，2023 年，专注于青少年心理健康的数位健康Start-Ups获得的投资占数位行为健康领域总资金筹措的 34%。

市场挑战

全球行为障碍治疗市场面临的一大阻碍因素是儿童精神科医师和心理健康专业人员的全球短缺。这种短缺在医疗保健服务系统中造成了严重的瓶颈，因为诊断行为障碍等疾病以及后续的药物和心理治疗管理都需要持证专业人员的严格监督。如果没有足够的专业人员来满足临床需求，患者的等待时间将显着延长，许多诊断甚至会被完全漏诊，从而有效地阻碍了潜在患者积极使用治疗产品。

这种结构性限制显着缩小了潜在市场规模，无论疾病盛行率或诊断意识如何。医疗服务提供者短缺的问题在关键的医疗保健统计数据中得到了清晰的体现：根据美国儿童和青少年精神病学会的数据，截至2024年，美国约有72%的县没有配备儿童和青少年精神科医生。这种专科医师的严重短缺意味着治疗性介入无法惠及广大民众，从而抑制了市场收入成长，并限制了治疗提供者的有效覆盖范围。

市场趋势

数位疗法与人工智慧驱动的分析技术的融合，正使基于软体的干预措施成为可报销的标准治疗方案，从根本上改变了市场格局。这些处方笺级应用程式利用人工智慧提供认知行为疗法并即时追踪症状，有效弥补了行为障碍儿童患者就诊间隔时间的不足。联邦监管机构建立正式的支付体系，进一步巩固了该方法的商业性可行性，并直接推动了医疗服务提供者的采用。在2024年11月发布的《2025财年医疗保险医师收费标准最终规则》中，美国医疗保险和医疗补助服务中心最终确定了三个专门用于数位心理健康治疗设备的新的HCPCS代码，从而建立了明确的报销途径，奖励将这些技术整合到行为健康计划中。

此外，住院和门诊护理模式的扩展导致了精神科服务的去中心化，从以机构为基础的通讯协定转向以家庭为中心的远距管理。远距精神科基础设施为这一转变提供了支持，使专业人员能够在家庭环境中开展直接的家长培训，从而克服了地域限制和医护人员严重短缺的问题。这种护理模式转变的持久性体现在其高使用率上，即使在疫情初期需求激增之后，其使用率仍然居高不下。根据加州公共卫生部于2024年6月发布的《儿童远距心理健康照护》报告，青少年远距心理健康服务的使用率比疫情前水准增加了30倍，凸显了市场向门诊照护和技术赋能的治疗方式的长期调整。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

5. 全球颠覆性行为障碍治疗市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（对立性反抗症、品行障碍、间歇性暴怒障碍）
  • 治疗方法类型（药物管理、全面评估、家庭治疗、教养指导、团体治疗、个别治疗、社交和情绪技能训练）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美破坏性行为障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲破坏性行为障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区行为障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲破坏性行为障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲破坏性行为障碍治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球破坏性行为障碍治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Eli Lilly and Company
• Pfizer Inc.
• Johnson & Johnson
• Boston Children's Hospital
• INTEGRIS Health
• H. Lundbeck A/S
• Springwoods Behavioral Health
• PrairieCare, LLC
• Valley Children's Healthcare
• Impireum Psychiatric Group

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Disruptive Behavior Disorder Treatment Market is projected to expand from USD 1.86 million in 2025 to USD 2.57 million by 2031, registering a compound annual growth rate of 5.54%. This market encompasses various pharmaceutical and psychotherapeutic interventions aimed at managing behavioral issues such as Oppositional Defiant Disorder and Conduct Disorder. The growth trajectory is primarily supported by the increasing clinical recognition of pediatric psychiatric conditions and the adoption of strong diagnostic frameworks that allow for earlier intervention. These foundational drivers are further strengthened by growing government financial support intended to merge mental health services with primary care systems. Highlighting the significant need for therapeutic management, the World Health Organization estimates that conduct disorder will affect approximately 3.3% of adolescents aged 10-14 years globally in 2025.

Despite these positive growth indicators, the market faces a substantial obstacle in the form of a severe global shortage of specialized child psychiatrists and mental health professionals. This lack of a sufficient workforce creates critical bottlenecks in diagnosing patients and delivering treatments, a problem that is particularly acute in developing regions. As a result, the scarce availability of trained providers limits the widespread implementation of therapeutic regimens, effectively restricting the potential market size even in the face of high clinical demand.

Market Driver

The rising prevalence of Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) acts as the main engine for market expansion, creating an urgent need to scale up therapeutic options. This increase in behavioral diagnoses reflects a wider decline in adolescent psychological well-being, fueling the demand for both medication-based and psychosocial interventions. Data from the Centers for Disease Control and Prevention's 'Youth Risk Behavior Survey Data Summary & Trends Report: 2013-2023', released in August 2024, reveals that roughly 40% of high school students experienced persistent feelings of sadness or hopelessness in 2023, emphasizing the severe need for enhanced behavioral health services. This expanding patient population forces healthcare providers to implement more aggressive diagnostic and treatment protocols to handle the increasing volume of disruptive behavioral symptoms.

Alongside this clinical demand is a significant increase in government-funded initiatives for pediatric mental health, which helps reduce barriers to care and subsidizes the cost of treatment. Both federal and state authorities are increasingly distributing grants to embed behavioral health services within schools and community centers, thereby directly widening the addressable market. For example, the Substance Abuse and Mental Health Services Administration announced in a July 2024 press release that it had awarded $15.3 million specifically to support children through school-based mental health services and aid for those with serious emotional disturbances. This surge in public investment is matched by private sector optimism; according to MedCity News in October 2024, investments in digital health startups focused on youth mental health represented 34% of all digital behavioral health funding in 2023.

Market Challenge

A severe constraint on the Global Disruptive Behavior Disorder Treatment Market is the critical global shortage of specialized child psychiatrists and mental health professionals. This deficit in the workforce creates a significant bottleneck within the healthcare delivery system because diagnosing conditions like Conduct Disorder and managing subsequent pharmaceutical or psychotherapeutic regimens demand strict supervision by licensed specialists. When the number of available professionals is insufficient to meet clinical needs, patient wait times increase dramatically, and numerous diagnoses are missed completely, effectively stopping potential patients from becoming active users of therapeutic products.

This structural limitation substantially shrinks the addressable market size, irrespective of how prevalent the disease is or how much diagnostic awareness exists. The gap in provider availability is clearly reflected in major healthcare statistics. According to the American Academy of Child and Adolescent Psychiatry, approximately 72% of counties in the United States did not have practicing child and adolescent psychiatrists in 2024. Such a profound lack of specialists implies that therapeutic interventions cannot reach a vast segment of the population, thereby impeding market revenue growth and limiting the effective scope of treatment providers.

Market Trends

The integration of Digital Therapeutics and AI-Driven Analytics is establishing software-based interventions as a reimbursed standard of care, which is fundamentally reshaping the market landscape. These prescription-grade applications employ artificial intelligence to administer cognitive behavioral therapy and track symptoms in real-time, effectively bridging the gap between clinical appointments for pediatric patients exhibiting disruptive behaviors. The commercial viability of this approach was solidified when federal regulators established formal payment structures, directly encouraging adoption by providers. In the 'Calendar Year (CY) 2025 Medicare Physician Fee Schedule Final Rule' released in November 2024, the Centers for Medicare & Medicaid Services finalized three new HCPCS codes specifically for digital mental health treatment devices, establishing a clear reimbursement pathway that incentivizes incorporating these technologies into behavioral treatment plans.

Furthermore, the expansion of home-based and outpatient care models is decentralizing psychiatric services, moving them toward remote, family-centered management and away from protocols that rely heavily on facilities. This transition is supported by tele-psychiatry infrastructure, which permits specialists to conduct behavioral parent training directly within the home setting, thereby surmounting geographic hurdles and severe provider shortages. The enduring nature of this shift in care delivery is demonstrated by utilization rates that remain high well past the initial urgency of the pandemic. According to the California Department of Public Health's 'Tele-Mental Health Care for Children' report from June 2024, the use of tele-mental health services for youth has sustained a 30-fold increase compared to pre-pandemic levels, highlighting the market's long-term reorientation toward outpatient and technology-enabled therapeutic access.

Key Market Players

• Eli Lilly and Company
• Pfizer Inc.
• Johnson & Johnson
• Boston Children's Hospital
• INTEGRIS Health
• H. Lundbeck A/S
• Springwoods Behavioral Health
• PrairieCare, LLC
• Valley Children's Healthcare
• Impireum Psychiatric Group

Report Scope

In this report, the Global Disruptive Behavior Disorder Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disruptive Behavior Disorder Treatment Market, By Type

• Oppositional Defiant Disorder
• Conduct Disorder
• Intermittent Explosive Disorder

Disruptive Behavior Disorder Treatment Market, By Treatment

• Medication Management
• Comprehensive Evaluation
• Family Therapy
• Parenting Modification
• Group Therapy
• Individual Therapy
• Social
• Emotional Skills Training

Disruptive Behavior Disorder Treatment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Disruptive Behavior Disorder Treatment Market.

Available Customizations:

Global Disruptive Behavior Disorder Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Disruptive Behavior Disorder Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder)
  • 5.2.2. By Treatment (Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, Social, Emotional Skills Training)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Disruptive Behavior Disorder Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Treatment
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Disruptive Behavior Disorder Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Treatment
  • 6.3.2. Canada Disruptive Behavior Disorder Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Treatment
  • 6.3.3. Mexico Disruptive Behavior Disorder Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Treatment

7. Europe Disruptive Behavior Disorder Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Treatment
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Disruptive Behavior Disorder Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Treatment
  • 7.3.2. France Disruptive Behavior Disorder Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Treatment
  • 7.3.3. United Kingdom Disruptive Behavior Disorder Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Treatment
  • 7.3.4. Italy Disruptive Behavior Disorder Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Treatment
  • 7.3.5. Spain Disruptive Behavior Disorder Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Treatment

8. Asia Pacific Disruptive Behavior Disorder Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Treatment
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Disruptive Behavior Disorder Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Treatment
  • 8.3.2. India Disruptive Behavior Disorder Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Treatment
  • 8.3.3. Japan Disruptive Behavior Disorder Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Treatment
  • 8.3.4. South Korea Disruptive Behavior Disorder Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Treatment
  • 8.3.5. Australia Disruptive Behavior Disorder Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Treatment

9. Middle East & Africa Disruptive Behavior Disorder Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Treatment
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Disruptive Behavior Disorder Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Treatment
  • 9.3.2. UAE Disruptive Behavior Disorder Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Treatment
  • 9.3.3. South Africa Disruptive Behavior Disorder Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Treatment

10. South America Disruptive Behavior Disorder Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Treatment
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Disruptive Behavior Disorder Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Treatment
  • 10.3.2. Colombia Disruptive Behavior Disorder Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Treatment
  • 10.3.3. Argentina Disruptive Behavior Disorder Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Treatment

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Disruptive Behavior Disorder Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Eli Lilly and Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Pfizer Inc.
• 15.3. Johnson & Johnson
• 15.4. Boston Children's Hospital
• 15.5. INTEGRIS Health
• 15.6. H. Lundbeck A/S
• 15.7. Springwoods Behavioral Health
• 15.8. PrairieCare, LLC
• 15.9. Valley Children's Healthcare
• 15.10. Impireum Psychiatric Group

16. Strategic Recommendations

17. About Us & Disclaimer